MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
270.88%
Quick Ratio
231.07%
Cash Ratio
47.36%
Debt to Asset Ratio
94.43%
Unit: Thousand (K) dollars
Assets Breakdown
    • Intangible assets, net
    • Goodwill
    • Accounts receivable, net and con...
    • Others
Liabilities Breakdown
    • Long-term debt, net
    • Current portion of long-term deb...
    • Retained earnings
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
163,138
309,749
133,820
419,665
Marketable securities, available-for-sale
67,865
8,873
9,000
282,298
Accounts receivable, net and contract assets
455,827
457,989
441,273
346,035
Inventories
137,135
155,467
176,475
185,796
Prepaid expenses and other current assets
109,059
70,958
64,639
94,955
Total current assets
933,024
1,003,036
825,207
1,328,749
Property and equipment, gross
83,700
82,149
77,601
71,634
Accumulated depreciation and amortization
33,936
35,215
33,159
31,059
Subtotal
49,764
46,934
44,442
40,575
Right of use of assets
34,507
35,296
37,695
30,845
Property and equipment, net
84,271
82,230
82,137
71,420
Prepaid expenses and other assets
55,090
50,915
53,551
55,698
Goodwill
581,732
582,323
580,360
416,821
Gross carrying value
-
-
-
538,200
Accumulated amortization
-
-
-
238,356
Total
-
-
-
299,844
Atrs-1902 (ipr&d)
-
-
-
48,700
Intangible assets, net
922,443
951,955
981,467
348,544
Deferred tax assets, net
-
-
0
0
Restricted cash
848
2,260
2,601
-
Total assets
2,577,408
2,672,719
2,525,323
2,221,232
Accounts payable
23,608
14,098
20,899
15,360
Accrued expenses
111,861
140,369
156,193
111,183
Current portion of long-term debt, net
208,970
208,743
-
710,685
Total current liabilities
344,439
363,210
177,092
837,228
Long-term debt, net
1,937,684
1,935,896
2,142,630
800,072
Other long-term liabilities
102,681
106,448
113,863
71,799
Deferred tax liabilities, net
49,061
47,529
42,924
8,218
Total liabilities
2,433,865
2,453,083
2,476,509
1,717,317
Common stock - 0.001 par value 300,000 shares authorized 114,042 and 117,782 shares issued and outstanding as of june30, 2026 and december31, 2025, respectively
114
118
118
118
Additional paid-in capital
0
27,386
12,002
23,909
Accumulated other comprehensive loss
-7,830
-12,703
-18,092
-22,258
Retained earnings
151,259
204,835
54,786
502,146
Total stockholders equity
143,543
219,636
48,814
503,915
Total liabilities and stockholders equity
2,577,408
2,672,719
2,525,323
2,221,232
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Property and equipment,gross$83,700K (21.64%↑ Y/Y)Accounts receivable, netand contract assets$455,827K (44.09%↑ Y/Y)Cash and cashequivalents$163,138K (163.72%↑ Y/Y)Inventories$137,135K (-24.45%↓ Y/Y)Prepaid expenses andother current assets$109,059K (42.28%↑ Y/Y)Marketable securities,available-for-sale$67,865K (-86.05%↓ Y/Y)Subtotal$49,764K (25.66%↑ Y/Y)Right of use of assets$34,507K (8.11%↑ Y/Y)Accumulated depreciationand amortization$33,936K (16.19%↑ Y/Y)Total current assets$933,024K (-16.89%↓ Y/Y)Intangible assets, net$922,443K (151.82%↑ Y/Y)Goodwill$581,732K (39.56%↑ Y/Y)Property and equipment,net$84,271K (17.83%↑ Y/Y)Prepaid expenses andother assets$55,090K (-2.27%↓ Y/Y)Restricted cash$848K Total assets$2,577,408K (25.49%↑ Y/Y)Total liabilities andstockholders equity$2,577,408K (25.49%↑ Y/Y)Total liabilities$2,433,865K (41.41%↑ Y/Y)Total stockholdersequity$143,543K (-56.86%↓ Y/Y)Accumulated othercomprehensive loss-$7,830K (72.43%↑ Y/Y)Long-term debt, net$1,937,684K (28.40%↑ Y/Y)Total currentliabilities$344,439K (156.50%↑ Y/Y)Other long-termliabilities$102,681K (32.03%↑ Y/Y)Deferred taxliabilities, net$49,061K Retained earnings$151,259K (-58.10%↓ Y/Y)Common stock - 0.001 parvalue 300,000 shares...$114K (-3.39%↓ Y/Y)Current portion oflong-term debt, net$208,970K Accrued expenses$111,861K (-3.23%↓ Y/Y)Accounts payable$23,608K (26.31%↑ Y/Y)

HALOZYME THERAPEUTICS, INC. (HALO)

HALOZYME THERAPEUTICS, INC. (HALO)